Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics

We are faced with a global pandemic of tuberculosis and new tools to control this disease are needed urgently. We believe that new drugs are central to any control strategy and the fastest route to tuberculosis elimination.
The consortium brings together a group of scientists from more that 14 countries with skills in clinical trials, pulmonology, mycobacteriology, pharmacokinetics, statistics and delivery of clinical service.


Our Scientific Network

PanACEA in “World TB Day 2014 – Reach the 3 Million”

On March 24, 2014, Michael Hoelscher (LMU) presented “Advances in New TB Drug Development”, Tim McHugh (UCL) “Approaches to Monitoring Therapy” and Patrick Phillips...


MAMS STUDY: Enrolment is Now Completed

On March 24 (on World TB Day), the MAMS TB-01 Study has completed enrolment ahead of schedule! We congratulate and thank everybody in achieving this goal prior to the...


MAMS study has completed first interim analysis

PanACEA, the Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics aims to develop TB regimens that significantly shorten treatment duration, funded...


Warning: require_once(/homepages/37/d463437192/htdocs/wp-content/themes/Chameleon/footer.php): failed to open stream: Permission denied in /homepages/37/d463437192/htdocs/wp-includes/template.php on line 407

Fatal error: require_once(): Failed opening required '/homepages/37/d463437192/htdocs/wp-content/themes/Chameleon/footer.php' (include_path='.:/usr/lib/php5.4') in /homepages/37/d463437192/htdocs/wp-includes/template.php on line 407